Esperion Therapeutics
ESPR
#7639
Rank
C$0.41 B
Marketcap
$2.08
Share price
-3.67%
Change (1 day)
-44.99%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$3.82

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.06. In 2022 the company made an earnings per share (EPS) of -$5.11 an increase over its 2021 EPS that were of -$13.75.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.82-25.25%
2022-$5.11-62.87%
2021-$13.7580.38%
2020-$7.6250.14%
2019-$5.08-53.18%
2018-$10.847.41%
2017-$10.10110.81%
2016-$4.7947.35%
2015-$3.250.89%
2014-$3.2228.84%
2013-$2.50-89.3%
2012-$23.37
2002-$9.858.89%
2001-$9.04-83.77%
2000-$55.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$14.73 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.12-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.68-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$53.73-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.92-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.98-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA